EP3-35 | 【 VC Talks 】The MedTech Visionary: Felix Oen’s Strategy for Clinical Innovation

Physician, entrepreneur, and mentor Felix Oen joins the show to share his insights on the "Golden Age of MedTech" (2022–2032). He breaks down the Biodesign framework—Identify, Innovate, and Implement—emphasizing that engineering brilliance must be validated by clinical science to succeed in the real world. For Taiwanese founders, Felix identifies two "make-or-break" factors for global expansion: partnering with a clinical co-founder and mastering the art of English pitching.

He also introduces NeoTILa Biosciences, his venture leveraging computational biology to tackle liver disease in Asian populations. Exploring the transformative power of AI in radiology and drug discovery, Felix predicts that AI will become the cornerstone of healthcare within the next five years. His ultimate vision? Using precision medicine and early detection to eradicate cancer once and for all.

本集邀請橫跨醫師、創業家與導師三重身份的 Felix Oen，深入解析 2022 至 2032 年生醫創新的「黃金十年」。Felix 拆解 Biodesign 的核心框架：從識別需求、創新研發到最關鍵的「臨床實踐」，強調工程技術必須與醫學數據驗證緊密結合。針對台灣創業者，他直言「尋找醫師共同創辦人」與「掌握英語簡報力」是進入美國與國際市場的生存關鍵。Felix 同時分享其創辦的 NeoTILa Biosciences 如何利用計算生物學對抗亞洲高發的肝病風險，並剖析 AI 在放射影像與藥物研發中的變革角色。他展望未來五年的醫療體系，期許 AI 成為精準醫療的基石，在極早期階段識別病灶，實現根除癌症的終極願景。

📍 About Host: Uly Su
General Partner, Addins Venture
#CrossBorderMentor #StartupExpansion #TaiwanToSiliconValley
🌏 A cross-border mentor who supports startups in entering global markets, with deep experience in fundraising, talent strategy, and international operations across the U.S. and Taiwan.
🔗 LinkedIn: https://www.linkedin.com/in/ulysu/

📚 Learn more about Taiwan’s startup ecosystem 👉🏼 https://meetstartup.pse.is/4jhd5u

🚀 Stay connected with Taiwan–Silicon Valley innovation via the Startup Island TAIWAN Silicon Valley Hub
Website: https://sv.startupisland.tw/
LinkedIn: https://www.linkedin.com/company/startup-island-taiwan-sv/
Facebook: https://www.facebook.com/people/Startup-Island-Taiwan-Silicon-Valley-Hub/61586221303202/